Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-21

Clinical Trial Update: A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial comparing plasma concentrations of a new and a marketed hydrocodone/acetaminophen tablet formulation in healthy adults was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocodone/Acetaminophen (hydrocodone bitartrate and acetaminophen)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Opioid-Related Disorders, Pain, Acute | Phase 1 | Status: WITHDRAWN